C12Y 207/01059
N-acetylglucosamine kinase
Official title: N-Acetylglucosamine kinase (2.7.1.59)
C12Y207/01059 (N-acetylglucosamine kinase) appears on 4 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 4
- Assignees
- 3
- Inventors
- 7
- Latest grant
- 8 Sep 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 2 |
| 2019 | 0 | 0 |
| 2020 | 2 | 0 |
By publication year.
Recent patents
- Bacterium for the production of an exopolysaccharide comprising N-acetylglucosamine and D-glucose8 Sep 2020US 10,767,205 B2DePuy Synthes Products, Inc.
- Bioresorbable exopolysaccharides28 Apr 2020US 10,633,682 B2DePuy Synthes Products, Inc.
- Modified live (JMSO strain) Haemophilus parasuis vaccine15 Sep 2015US 9,132,183 B2Newport Laboratories, Inc.
- Genetically engineered yeast for the production of biofuels11 Feb 2014US 8,647,855 B2New England Biolabs, Inc.
- Bioresorbable Exopolysaccharides13 Sep 2018US 2018/0258453 A1DePuy Synthes Products, Inc.
- Bioresorbable Exopolysaccharides13 Sep 2018US 2018/0258454 A1DePuy Synthes Products, Inc.
- Modified live (jmso strain) haemophilus parasuis vaccine6 Sep 2012US 2012/0225091 A1Newport Laboratories, Inc.
- Genetically Engineered Yeast for the Production of Biofuels3 Nov 2011US 2011/0269202 A1New England Biolabs, Inc.
Most cited
By later US patents